Andorra vs Least Developed Countries (LDCs): Proportion of the target population who received the final dose of
Andorra
82.0%
in 2024
Least Developed Countries (LDCs)
43.0%
in 2024
Andorra rank
20th
Least Developed Countries (LDCs) rank
20th
Proportion of the target population who received the final dose of over time
- Andorra
- Least Developed Countries (LDCs)
How they compare
Andorra currently reports 82.0% against 43.0% in Least Developed Countries (LDCs), a difference of 39.0%.
That makes Andorra's figure about 1.9 times Least Developed Countries (LDCs)'s.
Across all 7 years both countries report, Andorra has been ahead every year.
Andorra ranks 20th and Least Developed Countries (LDCs) ranks 20th of 107 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Least Developed Countries (LDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.5% | 6.5% | 50.0% | Andorra |
| 2020s | 82.0% | 21.4% | 60.6% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Andorra or Least Developed Countries (LDCs)?
- Andorra, at 82.0% against 43.0% in Least Developed Countries (LDCs) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Andorra and Least Developed Countries (LDCs)?
- 39.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Least Developed Countries (LDCs)?
- 7 years are reported by both, from 2018 to 2024.
- How do Andorra and Least Developed Countries (LDCs) rank globally for proportion of the target population who received the final dose of?
- Andorra ranks 20th and Least Developed Countries (LDCs) ranks 20th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.